Medical X-Ray Generator Market Worth $2.07 Billion By 2024

The global medical X-ray generator market is expected to reach USD 2.07 billion by 2024, according to a new report by Grand View Research, Inc. The unprecedented shift in lifestyle associated habits coupled with increasing prevalence chronic diseases, is responsible for the rise in demand for accurate diagnostic tools, which is presumed to bolster the market growth. In addition, global geriatric population base that is highly susceptible toward developing these chronic diseases is anticipated to impel the demand for high resolution imaging systems. This high requirement is effectively addressed by use of the medical x-ray generators, thus presenting the market with high growth potential throughout the forecast period.

In addition, these devices lead to better patient outcomes, which include faster detection of disease conditions, and improved patient safety profile. These associated benefits are expected to increase the overall adoption rate of these medical x-ray generators over the coming years

Furthermore, technological advancements such modification of the design of computer-controlled x-ray generator interface with imaging system results in better synchronization of the overall imaging system with x-ray generators. This has resulted in application of medical x-ray generators in fluoroscopy, radiography, and angiography, thus widening the potential for growth during the forecast period.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-x-ray-generator-market

Further Key Findings from the Study Suggest:

Stationary medical x-ray generators held the largest share of over 68.0% in the product segment in 2015. The dominant share can be attributed to low costs, high stability, and durability associated with the device, which is responsible for the high adoption rate in hospital settings.
Cardiovascular segment held the substantial share of over 20.0% in the application segment in 2015. The aforementioned is primarily a consequence of increasing prevalence of cardiovascular diseases. In addition, high demand for mono energetic x-ray generators for cardiovascular imaging, owing to its appropriate and safe intensity of energy projections, is presumed to provide growth potential to the Medical X-ray Generator Market.
In 2015, North America held a substantial share of the overall Medical X-ray Generator Market at over 30.0%. The presence of government regulatory authorities, consistently striving toward high patient safety is a significant factor that is presumed to be responsible for the largest market share of this region.
Furthermore, frequent product launch by prominent market players in the U.S. is presumed to be responsible for its largest share. For instance, In June 2015, Spellman High Voltage Electronics Corporation launched new range of radiography generators, Z series X-ray Generators. The product was launched at a relatively lower cost to cater to mid-tier medical radiography and veterinary imaging segments.
Some key players are increasingly involved in entering into collaborations and product launches to garner a larger share. For instance, in April 2015, Emd Technologies, Inc., launched a new range of EPS Unipolar High-Voltage Generators in the area of the mammography radiology segment. Moreover, in March 2015, Spellman announced to expand x-ray source product portfolio, through the launch of Monoblock x-ray sources with the introduction of XRBC Monoblock series.

Connected Car Market Size To Reach $180.30 Billion By 2022

The global connected car market size is expected to reach USD 180.30 billion by 2022, according to a new study by Grand View Research, Inc. Surging consumer demand, the constant need for connectivity, increased dependency on technology and the growing number of tech-savvy people are some of the factors expected to boost global connected car market growth.

Connected cars offer connectivity on wheels providing comfort, performance along with safety and security. Such advanced technology enables the driver and passengers to connect with various online platforms that facilitate real-time communication on the go.

The connected car market has the potential to significantly boost revenues of automobile manufacturers over the next five to seven years. Car manufacturers are expected to deliver the right mix of application and product packages for the right customers, and must systematically invest in R&D if they are willing to maintain their technological leadership.

Increasing regulations by governments and transportation authorities for the installation of advanced safety and vehicle to vehicle communications systems are expected to positively impact industry growth.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/connected-car-market

Further key findings from the study suggest:

Safety applications dominated the global connected car industry, accounting for over 34% of the share in 2014. The inclusion of safety technologies such as danger warning systems, automatic emergency calling, blind-spot alerts, anti-collision systems that prevent accidents in automobiles has made modern cars safer and accident-proof. This is expected to result in an overall reduction in road mishaps and accidents thus reducing the overall on-road fatalities.
Growing at a CAGR of over 31% from 2015 to 2022, driver assistance systems are expected to gain prominence over the forecast period. Recent advancements in driver assistance systems such as Volkswagen’s Emergency Assist, that automatically applies the brakes and stops a car in case of an emergency and BMW’s autonomous parking valet, that automatically parks a car even after the passenger’s exit have set benchmarks for driver assistance systems in the connected vehicle industry.
Asia Pacific is expected to grow at a CAGR of over 29% over the forecast period due to considerable automobile demand in the region coupled with a relatively untapped market for sophisticated automotive communications in the region. Countries such as China and India are expected to drive industry growth during the next seven years. Automobile manufacturers and technology giants across the world are striving hard to provide advanced vehicle management and safety technologies in the budget car segment as well. Regulation by the European department of transportation in association with the governments have mandated the installation of eCall emergence calling systems and other advanced telematics systems for safety purposes in all new vehicles manufactured after the year 2014.
Technological and product innovations have driven a highly dynamic market. Industry participants include major automobile manufacturers and telecommunication giants such as Audi AG, Alcatel Lucent, Apple Inc, BMW, Ford Motors, and Google Inc. Manufacturers resort to mergers, acquisitions, and strategic alliances with technological and network service providers as their key growth strategy to make their presence felt in the industry.

Vaccine Market Size Worth $77.5 Billion By 2024

The global vaccine market size valuation is expected to exceed USD 77.5 billion by 2024, at a CAGR of 10.3% according to a new report by Grand View Research, Inc. The development of various molecules to cater to the growing demand for vaccines can drive market demand. The majority of the key players are focused on vaccine development to gain an edge over competitors. For instance, Pfizer, Inc., is developing vaccines for Clostridium difficile, Staphylococcus aureus, and Meningococcal B.

Furthermore, the broad coalition of governments, worldwide, working to promote the awareness of vaccination benefits through immunization programs with the objective of containing the propagation of communicable diseases that are associated with high morbidity and mortality is expected to stimulate market growth.

For instance, the ‘Immunize Australia Program’ sponsors the immunization of individuals, which acts as a preventative action in preventing disease occurrence and checks rampant disease transmission thus protecting millions of Australians from severe diseases. Another program that has been involved in achieving extensive immunization coverage on the Indian continent is the National Immunization Program, a government program that has focused on taking strong preventive measures to offset vaccine-preventable diseases, particularly in children.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/vaccine-market

Further key findings from the study suggest:

The inactivated vaccine type segment was estimated to have over 14.5% market share in 2015 owing to the related advantages including easy storage and transport due to the highly stable nature of these vaccines. In December 2015, Sanofi Pasteur, Inc. launched a new trivalent, inactivated polio vaccine in India.
The DNA vaccine segment is presumed to be the fastest-growing type over the forecast period owing to the ease of production compared to the cell-based vaccines and the promising, targeted immunization outcomes coupled with the continual developments in the biotechnology area. Other advantages associated are ease of production, long-lasting immunogenicity, and no risk of reversion.
The cancer application segment is expected to witness the fastest growth with a CAGR of over 11.8% in the vaccinations market majorly attributable to the need for immunization against cancer coupled with the increasing prevalence of various types of cancer, such as cervical and colorectal cancers.
North America dominated the market in terms of revenue with over USD 12 billion in 2015, due mainly to the presence of extensive research and development activities and the existence of key participants of the industry in this region
Asia Pacific is identified to witness lucrative growth with a CAGR of around 10.7% during the forecast period due to the growing population base and the increasing economic growth of countries, such as China, Japan, and India. Moreover, the availability of skilled labors at a lower cost and the low manufacturing operations cost provide a platform for clinical trial outsourcing of the vaccinations under development to expedite commercialization.
Leading players in this industry, among others are, Merck & Co., Inc., Emergent BioSolutions, Inc., Johnson and Johnson, Sanofi Pasteur, Inc., Pfizer, Inc., Novartis AG, CSL Ltd., and GlaxoSmithKline Plc. Other prominent players include Abbott Laboratories, Inc., AstraZeneca plc, Janssen Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Ltd., and Valeant Pharmaceuticals International, Inc.
In April 2016, VBI vaccines, Inc. entered into a collaborative agreement with Sanofi Pasteur, Inc. to employ its “Lipid Particle Vaccine” formulation technology to better the stability of the Sanofi vaccines.

Wireline Logging Service Market Worth $34.39 Billion By 2022

The global wireline logging service market was valued at over USD 16 billion in 2014, according to a new study by Grand View Research, Inc. This can be attributed to the potential increase in recoverable resources and increased production & exploration. Increase in crude oil prices is estimated to result in rise in investments for exploration & production activities leading to significant new projects across the globe, which is expected to positively impact industry growth.

Technological advancements have broadened service offerings by oil & gas field service providers and improved industry efficiency. Several new technologies such as drill ships and Floating, Production, Storage, and Offloading (FPSO) vessels have enabled wells to be drilled in increasingly deep water. Additionally, the new reservoir conditions including high temperature, ultra-deep water, and high pressure require advanced logging tools and services. The aforementioned factors are projected to drive the industry demand over the next seven years.

Rise in the number of horizontal wells, demand for real-time logging, and well integrity concerns are estimated to offer significant opportunities for industry growth. However, increased seismic activities and stringent government regulations can hamper wireline logging service market.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/wireline-logging-service-market

Further key findings from the study suggest:

E-line logging segment accounted for over 55% of the revenue in 2014 and is expected to witness substantial rise in demand over the forecast period. It finds more usage as compared to the slickline products owing to its wide application across several E&P activities. Some of the factors responsible for electric line’s increased adoption include its ability to transmit electric data by offering a pathway for communication between the downhole equipment and the surface.
Cased-hole logging services segment is estimated to account for over 75% of the overall industry by 2022, growing at a CAGR of over 9% from 2015 to 2022. The industry has been developing sophisticated measurements in through-casing applications. Tools such as gamma ray, spectral gamma ray, pulse neutron, and compensated neutron are used for determining water saturation.
North America dominated the market in 2014 and is expected to grow at a CAGR of over 9% from 2015 to 2022. Potential increase in recoverable resources and completion activities within North America are expected to drive the demand across this region over the forecast period.
Wireline logging service market share is occupied by companies such as Halliburton, Schlumberger, Weatherford International, Baker Hughes, Nabors Industries, and Pioneer Energy Services. Profit margins of the companies are influenced on the efficiency of their production processes. Hence, major players such as Halliburton and Schlumberger are investing heavily in R&D for improving existing technologies, maintaining their edge. For instance, in 2014, Schlumberger invested USD 1.2 billion in R&D activities, whereas Halliburton invested USD 0.6 billion, Baker Hughes 0.6 billion, and Weatherford International invested USD 0.3 billion, respectively.

Cerebral Spinal Fluid Management Market Worth $1.4 Billion By 2022

The global cerebral spinal fluid (CSF) management market size is anticipated to reach USD 1.4 billion by 2022, according to a new report by Grand View Research, Inc. Constant evaluation of various techniques by neurosurgeons for improvement of hydrocephalus management is expected to drive growth in this market. Moreover, shunt manufacturers are engaged in the investment for the development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs.

A significant increase in the geriatric population across the globe as well as a rise in the incidence of chronic CNS associated disorders such as stroke can be attributed to projected growth. Furthermore, grants for research in neuromodulation therapies in order to develop different products for the prognosis of various nervous system associated disorders are expected to boost development.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/csf-management-market-analysis-market

Further Key Findings from the Study Suggest:

CSF management devices are expected to witness extensive competition owing to the presence of several market players operating in this segment. Rise in the number of CSF associated disorders such as trauma and stroke are anticipated to boost demand for these products in the coming years.
Cerebral spinal fluid management shunts captured the largest market share in terms of revenue generation in 2014.
These devices are most commonly used for supplementing and replacing lost drainage capacity in case of CSF leak management.
CSF drainage is anticipated to witness lucrative growth over the forecast period.
This growth can be attributed to ongoing development for enhancing the overall safety of guidance-based systems and anti-biotic impregnated catheters incorporation.
In 2014, North America accounted for the largest share with respect to revenue generation.
Factors contributive for the share include a continuous increase in the number of Americans affected by Hydrocephalus coupled with ongoing research in neuroscience.
Asia Pacific is expected to propel with the fastest CAGR owing to constantly improving the healthcare system in the region.
Moreover, the economic progress of Asia Pacific countries such as China has led to a significant transformation of neurology and neurologic practices in the country. This is one of the key drivers to propel progress in this region in the coming years.
Some of the key players operating in the cerebrospinal fluid management market include Johnson & Johnson Services, Inc; B.Braun Melsungen AG; Magstim; Elekta AB; Medtronic, Inc.; Integra LifeSciences Corporation; Phoenix Biomedical Corp.; Sophysa; Spiegelberg GmbH & Co. KG; and Beckersmith Medical, Inc.
These players are engaged in the development of novel platforms for CSF management.

Automotive Vehicle-to-Everything Market Worth $26.72 Billion By 2025

The global automotive vehicle-to-everything (V2X) market is expected to reach USD 26.72 billion by 2025 according to a new report by Grand View Research, Inc. The automotive industry is undergoing a series of transitions, the industry moving towards digitalization and connected mobility. There has been a significant rise in the use of electronics in vehicles. The vehicles today have shifted from being a conventional vehicle to intelligent vehicles and are equipped with communication systems that alert or assist the driver from a potential accident. Moreover, the rising consumer demand for convenience features has enforced various OEMs to incorporate V2X communication systems. The implementation of the V2X communication will not only increase the safety aspect but will also provide enhanced driving experience.

There are numerous benefits for the implementation of V2X communication systems, however, they are surrounded by challenges. The main challenge for the automotive V2X market to grow is the need for a robust legal framework. Another important challenge is to build a secure system that ensures privacy, authenticity, and security for all types of V2X communication.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/automotive-vehicle-to-everything-v2x-market

Further key findings from the report suggest:

Increasing concerns towards environment and growing electric vehicles market will provide wide growth opportunities for V2H, V2G, and V2I communication type market
With the automotive industry moving towards connected cars and autonomous driving, there will arise concerns about data security, anonymity, and privacy maintained.
Synchronized real-time data will be a key factor in determining the growth of the automotive V2X market.
The automotive V2X market is anticipated to grow at a CAGR of over 25.4% from 2016 to 2024.
Major players of the automotive V2X market are Continental AG, Qualcomm Inc., Robert Bosch GmbH, NXP Semiconductors N.V., Tomtom N.V., Cisco Systems Inc., and Infineon Technologies AG, among others.
The automotive industry has numerous technology giants who are investing heavily in the automotive V2X market in order to gain the first movers advantage.

North America PoC Diagnostics Market Worth $8.95 Billion By 2024

The North America point of care diagnostics market is anticipated to reach USD 8.95 billion by 2024, according to a new report by Grand View Research, Inc. Incorporation of advanced information technology solutions coupled with the launch of innovative POC products with automation and ease of use is projected to influence market progression during the forecast period.

Moreover, the rising adoption rate of the POC devices in order to obtain quick results for immediate decision making for patient management is expected to provide the market with lucrative growth avenues. Additionally, the regulatory initiatives introduced for patient care management and rising prevalence of various diseases is attributive to boost demand for these products in the coming years.

The presence of a favorable funding environment in the region is attributive to drive R&D in academic organizations and universities thereby resulting to industrial progress through to 2024.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/north-america-point-of-care-poc-diagnostics-market

Further key findings from the report suggest:

Glucose testing accounted for the largest share of over 41% of the market in 2015 with respect to revenue generation. Factors attributive for the estimated large share includes presence of comprehensive product portfolio provided by the local as well as international market participants. Moreover, rise in the prevalence of diabetes in chronic patients and need for monitoring glucose levels is also supportive for revenue generation of this segment.
Infectious diseases point-of-care tests are expected to witness the fastest growth in the coming years owing to the R&D carried out in this segment for an introduction of novel tests. Infectious disease testing segments include kits for various diseases such as HIV, HBV, respiratory syncytial virus (RSV), pneumonia or streptococcus associated infections, HPV, influenza/flu, HCV, MRSA, Clostridium difficile, TB &drug-resistant TB, and HSV.
Cardiac markers are also anticipated to register substantial growth as a result of an increase in incidence rate of cholesterol associated disorders and rise in the number of cases of congestive heart failure.
Clinics dominated the POC diagnostic market in 2015 due to higher usage of these tests in clinics. However, home settings for POC diagnostics are anticipated to witness the fastest growth owing to rising usage of home health care settings for disease monitoring in the geriatric population.
Assisted living healthcare facilities are also anticipated to witness considerable growth during the forecast period due to the property of rapid diagnostic products to enable simple usage at primary care level and in remote settings even with no laboratory infrastructure
Prominent players of this industry include Qiagen N.V., Spectral Diagnostics, Abbott Laboratories, Siemens Healthcare, Instrumentation Laboratory, Danaher Corporation, BioMerieux, Johnson & Johnson, Abaxis Inc., Roche Diagnostics, Alere Inc., Nova Biomedical, Nipro Diagnostics, and Trinity Biotech.
Strategies adopted by the market players include mergers and acquisitions with the smaller entities operating in market for enhancement of the product portfolio. The participants are involved introduction of new solutions, and collaborations with heath care institutions in order to maintain their global presence.

U.S. MVNO Market Size Worth $32.19 Billion By 2025

The U.S. mobile virtual network operator (MVNO) market size is expected to reach USD 32.19 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.2% CAGR during the forecast period. Increasing demand for value-added services (VAS) over voice services has led to a rise in the adoption of MVNO in U.S.

Increasing demand for roaming MVNO model owing to rise in number of travelers in the country has greatly propelled the U.S. MVNO market over the forecast period. Additionally, MVNO operators have been offering service sets at lower costs, which is expected to considerably aid market growth.

Soaring demand for smartphones and mobile broadband, along with technological advancements and development of compact, lightweight, and multifunctional devices, is anticipated to significantly drive the U.S. market. Expansion of communication technologies such as LTE 4G and 5G as well as expansion of Wi-Fi offer growth opportunities for players.

A key trend that has been observed in the U.S. market is that MVNOs in the country allow their users to personalize their plans for meeting text, data, and voice demands. Increasing advancements in LTE infrastructure, which provides services such as VoLTE, ViLTE, and VoWiFi, is expected to offer growth prospects to market players over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/us-mvno-market

Further key findings from the report suggest:

The U.S. MVNO market is expected to project a CAGR of 7.2% over the forecast period, owing to increasing number of mobile subscribers in the country
By type, the discount segment is anticipated to dominate the market, with a revenue of USD 7.73 billion in 2025. This growth can be attributed to intense competition in the market, which encourages MVNOs to offer various discounts on voice, data, and text to retain existing users and attract new ones
On the basis of operational mode, the full MVNO segment is expected to reach USD 19.35 billion by 2025, owing to low capital investment required in setting it up
By way of end use, the consumer segment emerged dominant and is anticipated to register a CAGR of 7.0% over the forecast period. This growth can be attributed to growing advancements in high-speed mobile broadband and availability of low-cost smartphones in the market
Key industry participants include 7-Eleven Speak Out Wireless, AirVoice Wireless, Asahi Net, Boost Mobile LLC, CJ HelloVision Co. Ltd, and Cyfrowy Polsat SA.

Bioinformatics Services Market Worth $4.1 Billion By 2024

Global bioinformatics services market is anticipated to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of I.T. solutions for different studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation are expected to support growth in this market over the forecast period.

Owing to the benefits associated with the use of informatic solutions for laboratory protocol generation and data management as well as analysis, these solutions are projected to witness substantial demand in the coming years.

Moreover, collaborative activities undertaken by the information technology companies with pharmaceutical companies and clinical research organizations in order to develop and update key technologies linked to cloud computing, like online data storage and visualization of computer resources are expected to enhance market potential through to 2024.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/bioinformatics-services-market

Further key findings from the report suggest:

NGS is estimated to be the dominant segment with respect to the type of service served in 2015 owing to the fact that sequence-based approach of analysis can be cataloged with the structure-based approach as complementary to genomic and proteomic approaches. Advancement in the sequencing technologies such as NGS and scripting tools (Perl & Python) for sequence manipulation coupled with the reduction in prices of the sequencing platforms and market movement towards the USD 1,000 genome resulted in a larger revenue share of this segment in the discovery informatics.
Market revenue from of chemoinformatics is second only to NGS and its strong market position can be accounted for by presence of several entities operating in this segment and their involvement in the provision of lead identification, validation, assay development, lead generation, optimization, and clinical trial based informatic solutions.
Depending on the application, transcriptomics is anticipated to register the fastest growth of over 15% owing to rise in the number of projects carried out in translational research and application of RNA transcripts for studying etiology of chronic as well as acute diseases.
Academic sector, in terms of end-use for these services, is expected to witness the fastest growth through to 2024 as a result of rise in the adoption rate of these technologies in genomic, proteomic and metabolomics research programs carried out by universities research institutes. If not all, most of these programs are either backed through government funding or private corporation backing and forms a considerable part of the high R&D investment that the bioinformatics market attracts in the current scenario.
North America dominated the industry in 2015, accounting for a little 35% of total revenue. Presence of key participants operating in the region which are involved in development of novel algorithms and software in order to improve drug attrition rates which consequently increases adoption rate of computational algorithms is attributive for the largest share of North America in sector revenue. Demand for informatic services in Europe is also increasing owing to the presence of universities in Germany and UK that are involved in development of I.T. solutions for pharmaceutical research.
Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the fact that government and regulatory authorities have implemented a framework to encourage R&D collaborations and framework extension. Active expansion strategies undertaken by a number of the major market entities operating in the American market in order to strengthen their position in Asia Pacific region is a factor anticipated to consequently drive growth.
Key players operating in this industry include Agilent technologies, Siegen Inc., GVK Biosciences, Accelerys Inc, Illumina Inc., DNAnexus, Life Technologies Corporation, Geneva Bioinformatic, Celera Corporation, IBM Life sciences, and Affymetrix.
These entities are adopting strategies such as collaborations with pharmaceutical and biotechnology companies in order to enhance industrial presence by providing different data management and analytical services for the purpose of drug design and therapeutic monitoring.

Anesthesia Monitoring Devices Market Worth $1.9 Billion By 2024

The anesthesia monitoring devices market is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base and the spiraling number of surgeries are anticipated to boost the market growth. Geriatric patients are the target population for this industry as they are highly prone to various chronic disorders and are at a higher risk of developing complications.

The rising awareness amongst the physicians about the various factors that affect patient outcomes, such as the choice of anesthetic drug, the appropriate route of administration, and the right dose of the anesthetic agent, as well as the monitoring of the depth of anesthesia is likely to accelerate the growth of the market during the forecast period.

Technological advancements in terms of accuracy, portability, and affordability have resulted in the increased usage of these monitoring devices. For instance, the introduction of the new generation, microprocessor-based intelligent anesthesia systems with integrated monitors enables monitoring of various parameters along with the precisely-controlled administration of the anesthetic agent.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/anesthesia-monitoring-devices-market

Further key findings from the study suggest:

Amongst the product type segments, the advanced anesthesia monitors segment held a lucrative share of over 60.0% in 2015 owing to its durability, reliability, and accuracy. Moreover, these devices monitor various significant parameters such as oxygen saturation level, carbon dioxide level, heart rate, and blood pressure.
The hospitals in the end-use segment exhibited remunerative growth in 2015; this can be attributed to the presence of advanced diagnostic and therapeutic medical technologies that enables both, faster and accurate diagnosis. Moreover, the availability of these advanced systems coupled with the presence of skilled personnel contributes towards profitable growth of this segment.
North America dominated the overall market with a revenue share of over 35.0% in 2015 owing to the presence of well-developed health care settings and the presence of a favorable reimbursement network, government funding, and increasing health awareness levels amongst the people.
However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 11.0% over the forecast period. The economic developments and the advancing healthcare system with the aid of supportive government initiatives are collectively anticipated to further assist the growth in this region.
Some key players operating in the anesthesia monitoring devices market include Masimo Corporation, Infinium Medical, Inc., Medtronic plc, GE Healthcare, Nihon Kohden Corporation, Philips Healthcare, Mindray Medical International Ltd., Drägerwerk AG & Co. KGaA, and Schiller AG. New product development, mergers, and collaborations are some key initiatives taken to sustain themselves in the competition.
For instance, Masimo Corporation incorporated Oxygen Reverse Index (ORI) which measures the oxygen levels and provides real-time information with regard to the patient’s oxygen reserve in synchronization with the partial pressure of oxygen to prevent hyperoxia conditions (oxygen levels above normal) in patients that are receiving auxiliary oxygen supply whilst undergoing surgery.